Trial Profile
Randomized, placebo controlled, double blind trial of telmisartan in hypertensive, obese adolescents
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 16 Mar 2020 Status changed from recruiting to discontinued.
- 04 Dec 2007 New trial record.